EyePoint Pharmaceuticals, Inc. Gains 24.12%
Mon, Mar 27, 2023 at 07:13 PM
EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ) soared at $2.83, representing a gain of 24.1%. On Mon, Mar 27, 2023, EYPT:NASDAQ touched a New 2-Week High of $2.83. The stock appeared on our News Catalysts scanner on Mon, Mar 27, 2023 at 08:40 AM in the 'BIOTECH' category. From Mon, Mar 13, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Jan 13, 2023 at $5.8 with a volume of 1M+.
About EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ)
pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Top 10 Gainers:
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 89.47%
- SRAX, Inc. (SRAX:NASDAQ), 46.31%
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 41.15%
- CBL International Limited (BANL:NASDAQ), 39%
- Cimpress plc (CMPR:NASDAQ), 33.97%
- Loop Industries, Inc. (LOOP:NASDAQ), 32.63%
- Alimera Sciences, Inc. (ALIM:NASDAQ), 31.21%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 30.66%
- Local Bounti Corporation (LOCL:NYSE), 25.21%
- EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ), 24.12%